| Measles in Europe: an epidemiological assessment M Muscat, H Bang, J Wohlfahrt, S Glismann, K Mølbak The Lancet 373 (9661), 383-389, 2009 | 303 | 2009 |
| Who gets measles in Europe? M Muscat The Journal of Infectious Diseases 204 (suppl_1), S353-S365, 2011 | 200 | 2011 |
| Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system methodology in Canada JM Hutchinson, DM Patrick, F Marra, H Ng, WR Bowie, L Heule, M Muscat, ... Canadian Journal of Infectious Diseases and Medical Microbiology 15 (1), 29-35, 2004 | 162 | 2004 |
| High genetic diversity of measles virus JR Kremer, KE Brown, L Jin, S Santibanez, SV Shulga, Y Aboudy, ... World Health Organization European Region 2006, 107-14, 2005 | 113* | 2005 |
| Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010 I Parent du Châtelet, D Antona, F Freymuth, M Muscat, ... Eurosurveillance 15 (36), 2010 | 106 | 2010 |
| The state of measles and rubella in the WHO E uropean R egion, 2013 M Muscat, A Shefer, M Ben Mamou, R Spataru, D Jankovic, S Deshevoy, ... Clinical Microbiology and Infection 20, 12-18, 2014 | 105 | 2014 |
| Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001 B Müller-Pebody, M Muscat, B Pelle, BM Klein, CT Brandt, DL Monnet Journal of antimicrobial chemotherapy 54 (6), 1122-1126, 2004 | 83 | 2004 |
| Measles and rubella elimination in the WHO Region for Europe: progress and challenges P O'Connor, D Jankovic, M Muscat, M Ben-Mamou, S Reef, M Papania, ... Clinical Microbiology and Infection 23 (8), 504-510, 2017 | 81 | 2017 |
| Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007 H De Carvalho Gomes, M Muscat, DL Monnet, J Giesecke, PL Lopalco Eurosurveillance 14 (12), 2009 | 79 | 2009 |
| Progress toward measles elimination—European region, 2009–2018 LA Zimmerman MMWR. Morbidity and mortality weekly report 68, 2019 | 68 | 2019 |
| Progress and challenges in measles and rubella elimination in the WHO European Region SS Datta, PM O'Connor, D Jankovic, M Muscat, MCB Mamou, S Singh, ... Vaccine 36 (36), 5408-5415, 2018 | 63 | 2018 |
| Towards equity in immunisation T Boyce, A Gudorf, C de Kat, M Muscat, R Butler, KB Habersaat Eurosurveillance 24 (2), 1800204, 2019 | 62 | 2019 |
| The measles outbreak in Bulgaria, 2009–2011: An epidemiological assessment and lessons learnt M Muscat, L Marinova, A Mankertz, N Gatcheva, Z Mihneva, S Santibanez, ... Eurosurveillance 21 (9), 30152, 2016 | 55 | 2016 |
| Patterns of antibiotic use in the community in Denmark M Muscat, DL Monnet, T Klemmensen, L Grigoryan, ... Scandinavian journal of infectious diseases 38 (8), 597-603, 2006 | 53 | 2006 |
| Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase S Santibanez, JM Hübschen, MCB Mamou, M Muscat, KE Brown, R Myers, ... Clinical Microbiology and infection 23 (8), 516-523, 2017 | 48 | 2017 |
| Measles in Europe in 2001-2002 M Muscat, S Glismann, H Bang Eurosurveillance 8 (6), 123-129, 2003 | 48 | 2003 |
| An update on an ongoing measles outbreak in Bulgaria, April-November 2009 L Marinova, M Muscat, Z Mihneva, M Kojouharova Eurosurveillance 14 (50), 19442, 2009 | 42 | 2009 |
| Toward rubella elimination in Europe: an epidemiological assessment M Muscat, L Zimmerman, S Bacci, H Bang, S Glismann, K Mølbak, S Reef Vaccine 30 (11), 1999-2007, 2012 | 33 | 2012 |
| Measles is still a cause for concern in Europe M Muscat, H Bang, S Glismann Eurosurveillance 13 (16), 18837, 2008 | 29 | 2008 |
| DANMAP 2003: Use of antimicrobial agents and occurence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark OE Heuer, PB Larsen, VF Jensen, HD Emborg, AM Hammerum, C Brandt, ... | 29 | 2004 |
Neville CallejaAssociate Professor in Public Health and Medical Statistics, University of Malta在 um.edu.mt 的电子邮件经过验证
Neville CallejaAssociate Professor in Public Health and Medical Statistics, University of Malta在 um.edu.mt 的电子邮件经过验证